Printer Friendly

Browse Pharmaceutical industry topic

Licensing agreements subtopic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Switzerland : Relief Therapeutics Holding Sa Announces Divestment of Its Subsidiary Relief Therapeutics Sa to Sonnet Biotherapeutics, Inc. To Ensure the Development of Atexakin Alpha. Aug 17, 2019 535
Cocrystal Pharma reports Q2 revenue $592,000 vs. no revenue last year. Financial report Aug 9, 2019 111
Dechra Pharma To Work With Akston Biosciences On Dog Diabetes Drug. Aug 2, 2019 277
BioInvent receives payment of USD300,000 from Pfizer on selection of first target under cancer immunotherapy agreement. Aug 1, 2019 168
BioInvent receives payment of USD300,000 from Pfizer on selection of first target under cancer immunotherapy agreement. Aug 1, 2019 169
BioInvent receives payment of USD300,000 from Pfizer on selection of first target under cancer immunotherapy agreement. Aug 1, 2019 164
Verastem, Sanofi sign licensing agreement. Jul 29, 2019 185
Verastem, Sanofi sign licensing agreement. Jul 29, 2019 181
Lexicon Shares Fall 47% On Termination Of License Agreement With Sanofi. Jul 29, 2019 189
Verastem Oncology Inks Exclusive License Agreement with Sanofi for the Development and Commercialisation of Copiktra in Russia and CIS, Turkey, the Middle East and Africa. Jul 29, 2019 372
Sanofi granted rights to develop and commercialise COPIKTRA from Verastem. Jul 26, 2019 239
Sanofi granted rights to develop and commercialise COPIKTRA from Verastem. Jul 26, 2019 235
Hikma Pharma Inks Africa And Middle East Commercial Deal With Gedeon. Jul 25, 2019 196
Verastem signs commercialization agreement with Sanofi for Copiktra in EMEA. Jul 25, 2019 146
Crescendo Biologics' Second Oncology-targeted Humabody Licensed by Takeda. Jul 24, 2019 338
Jounce announces update on strategic collaboration with Celgene. Jul 23, 2019 300
Boehringer Ingelheim signs collaboration and licence agreement with Bridge Biotherapeutics. Jul 22, 2019 148
Boehringer Ingelheim signs collaboration and licence agreement with Bridge Biotherapeutics. Jul 22, 2019 144
Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics. Jul 19, 2019 289
Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss. Jul 18, 2019 458
China Medical System Holdings Ltd. (0867. HK) Strategically Introduces Overseas Launched Blockbuster Innovative Products. Jul 16, 2019 2190
India,United States : Glenmark & Torrent sign licensing agreement for co-marketing of Remogliflozin Etabonate in India. Jul 15, 2019 409
MacroGenics and I-Mab partner to develop and commercialize enoblituzumab in Greater China. Jul 11, 2019 241
MacroGenics and I-Mab partner to develop and commercialize enoblituzumab in Greater China. Jul 11, 2019 237
India : Glenmark & Torrent sign licensing agreement for co-marketing of Remogliflozin Etabonate in India. Jul 11, 2019 408
Japan Pharmaceuticals Industry - Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist -- 24/6/2019. Jul 9, 2019 1045
Germany : Boehringer Ingelheim Expands Nonalcoholic Steatohepatitis (NASH) R&D Pipeline With New First-in-Class Compound from Yuhan Corporation. Jul 6, 2019 721
Boehringer Ingelheim Expands Nonalcoholic Steatohepatitis R and D Pipeline with New First-in-Class Compound from Yuhan Corp. Jul 5, 2019 409
Japan Pharmaceuticals Industry - Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist -- 24/6/2019. Jul 4, 2019 1079
Boehringer Ingelheim signs collaboration and license agreement with Yuhan. Jul 4, 2019 202
Boehringer Ingelheim signs collaboration and license agreement with Yuhan. Jul 4, 2019 198
Incyte partners with Zai Lab for INCMGA0012 in Greater China. Jul 3, 2019 219
Incyte partners with Zai Lab for INCMGA0012 in Greater China. Jul 3, 2019 215
Incyte, Zai Lab enter into collaboration, license agreement for INCMGA0012. Jul 2, 2019 133
India : Takeda and BE Collaborate to Develop Low-Cost Vaccines for Low and Middle-Income Countries. Jun 29, 2019 542
Liquidia Technologies and GlaxoSmithKline restructure collaboration agreement. Jun 26, 2019 190
Japan Pharmaceuticals Industry - Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist -- 24/6/2019. Jun 25, 2019 1003
Deciphera Pharmaceuticals, Zai Lab Ink Exclusive License Agreement for Ripretinib in Greater China. Jun 13, 2019 539
Mesoblast and JCR Pharma expand partnership in Japan to the use of MSCs. Jun 11, 2019 226
Deciphera, Zai Lab announce ripretinib license agreement in Greater China. Jun 11, 2019 169
Deciphera, Zai Lab announce exclusive license agreement for ripretinib. Jun 11, 2019 170
Eli Lilly & Company (NYSE: LLY) - Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics -- 28/5/2019. Jun 4, 2019 351
VECTURA (LSE: VEC) - Vectura receives $2.5m milestone payment for the European regulatory submission of QVM149 -- 24/5/2019. Jun 4, 2019 252
Starpharma enters into second DEP oncology agreement with AstraZeneca. Jun 4, 2019 204
Starpharma enters into second DEP oncology agreement with AstraZeneca. Jun 4, 2019 200
United States : Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics. Jun 1, 2019 349
Boehringer Ingelheim signs second collaboration and license agreement with Gubra. May 31, 2019 199
Boehringer Ingelheim signs second collaboration and license agreement with Gubra. May 31, 2019 195
ADC Therapeutics Expands to Third Programme Using Synaffix's ADC Platform Under Existing Agreement. May 30, 2019 362
Zymeworks achieves USD2.0m milestone payment from Merck. May 29, 2019 181
Zymeworks achieves USD2.0m milestone payment from Merck. May 29, 2019 177
VECTURA (LSE: VEC) - Vectura receives $2.5m milestone payment for the European regulatory submission of QVM149 -- 24/5/2019. May 29, 2019 252
Ligand Pharmaceuticals grants Cumulus Oncology rights to develop and commercialise VER250840. May 21, 2019 162
Ligand Pharmaceuticals grants Cumulus Oncology rights to develop and commercialise VER250840. May 21, 2019 158
Eisai Co., Ltd. - Eisai Enters Into Licensing Agreement With Medac Concerning Anti-Rheumatic Agent Methotrexate Subcutaneous Injection In Japan -- 10/5/2019. May 15, 2019 515
Eisai Europe - Eisai Enters Into Licensing Agreement With Medac Concerning Anti-Rheumatic Agent Methotrexate Subcutaneous Injection In Japan -- 10/5/2019. May 15, 2019 328
GlycoMimetics Completes Enrollment for Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease. May 8, 2019 560
Transgene signs collaborative research, option and exclusive license agreement with AstraZeneca. May 6, 2019 222
Transgene signs collaborative research, option and exclusive license agreement with AstraZeneca. May 6, 2019 218
GlycoMimetics completes enrollment for Phase 3 trial evaluating rivipansel. May 6, 2019 161
Emendo Biotherapeutics signs licensing option agreement with Takeda. Apr 25, 2019 204
Emendo Biotherapeutics signs licensing option agreement with Takeda. Apr 25, 2019 200
HitGen signs drug development licence agreement with Kaken. Apr 11, 2019 153
HitGen signs drug development licence agreement with Kaken. Apr 11, 2019 149
Xencor and Astellas Enter Collaboration for Novel Bispecific Antibody Program. Apr 3, 2019 234
Vect-Horus Enters Collaboration and License Agreement with Ono Pharmaceutical. Mar 28, 2019 248
Ichor Medical Systems Forges Collaboration and Research License Agreement with AstraZeneca to Develop DNA-based Monoclonal Antibody Platform. Mar 28, 2019 342
Lilly signs licensing and research collaboration with ImmuNext. Mar 27, 2019 199
Lilly signs licensing and research collaboration with ImmuNext. Mar 27, 2019 195
LegoChem Biosciences partners with Takeda for development of antibody-drug conjugates in immuno-oncology. Mar 22, 2019 202
LegoChem Biosciences partners with Takeda for development of antibody-drug conjugates in immuno-oncology. Mar 22, 2019 198
Enigma Biomedical Inks License Agreement with US Merck for Novel MK-6884 Imaging Agent. Mar 19, 2019 308
Enigma Biomedical Group & Merck partnership to develop novel imaging agent MK-6884. Mar 18, 2019 233
Enigma Biomedical Group & Merck partnership to develop novel imaging agent MK-6884. Mar 18, 2019 229
Japanese Firms Test Dental Pulp Stem Cell-based Product In Clinical Trial. Mar 18, 2019 335
Japanese Firms Test Dental Pulp Stem Cell-based Product In Clinical Trial. Mar 18, 2019 333
Japanese Clinical Trial Tests Dental Pulp Stem Cell-based Stroke Treatment. Mar 11, 2019 333
Infinity Pharmaceuticals announces royalty monetization of $30M from Verastem. Mar 6, 2019 166
Germany : Successful licensing agreement between Bayer AG, KWS SAAT SE and MariboHilleshog. Mar 5, 2019 332
United States : Argenx Inks $1.6 Billion Agreement With Janssen Affiliate. Mar 5, 2019 237
Principia Biopharma presents Phase 1 PRN2246 data at ACTRIMS. Mar 1, 2019 286
Moberg Pharma announces signing of exclusive license agreement with Bayer for commercialisation of MOB-015 in Europe. Feb 12, 2019 191
Moberg Pharma announces signing of exclusive license agreement with Bayer for commercialisation of MOB-015 in Europe. Feb 12, 2019 187
Moberg Pharma, Bayer sign exclusive license agreement for MOB-015 in Europe. Feb 11, 2019 168
Janssen Pharmaceuticals signs contract with MeiraGTx. Feb 4, 2019 169
Janssen Pharmaceuticals signs contract with MeiraGTx. Feb 4, 2019 165
Johnson & Johnson subsidiary enters collaboration with MeiraGTx. Jan 31, 2019 132
Merck KGaA grants license to Vertex for two DNA damage response inhibitors. Jan 24, 2019 134
Ablexis Expands Non-Exclusive Perpetual License Agreement with Eli Lilly and Company. Jan 18, 2019 234
Biomunex Pharmaceuticals signs licensing agreement with Sanofi. Jan 17, 2019 161
Biomunex Pharmaceuticals signs licensing agreement with Sanofi. Jan 17, 2019 157
Bioharmony Therapeutics, Boehringer Ingelheim Team to Advance Bacteriophage Lysin Therapeutics for the Treatment of Multi-Drug Resistant Bacterial Infections. Jan 16, 2019 337
Alopexx Vaccine enters into equine vaccine licensing agreement with Merck Animal Health. Jan 15, 2019 230
China's Bio-Thera Solutions Partners with Cipla to Market Key Cancer Biosimilar. Jan 14, 2019 377
4D pharma names new independent non-executive directors. Jan 9, 2019 168
4D pharma names new independent non-executive directors. Jan 9, 2019 164
CANbridge Pharmaceuticals and GC Pharma Ink Greater China Licensing Agreement for Hunterase for Hunter Syndrome. Jan 9, 2019 414
Boehringer Ingelheim exercises option to receive exclusive rights to second hepatic disease target from Dicerna collaboration. Jan 8, 2019 251
Boehringer Ingelheim exercises option to receive exclusive rights to second hepatic disease target from Dicerna collaboration. Jan 8, 2019 247
Xencor regains ex-U.S. commercial rights to XmAb13676 from Novartis. Jan 7, 2019 106
Amunix signs therapeutics licensing agreement with Merck. Jan 4, 2019 160
Amunix signs therapeutics licensing agreement with Merck. Jan 4, 2019 156
MyoKardia regains rights to all programs under Sanofi license agreement. Jan 2, 2019 356
Opiant Pharmaceuticals signs licensing agreement with Sanofi. Dec 28, 2018 131
Opiant Pharmaceuticals signs licensing agreement with Sanofi. Dec 28, 2018 127
Ayala Pharmaceuticals to Develop and Commercialise AL102 in Combination with BCMA Targeting Agents in Multiple Myeloma. Dec 26, 2018 415
Neos Therapeutics and Teva settle XR-ODT patent litigation case. Dec 26, 2018 112
Opiant Pharmaceuticals licenses drinabant for ACO from Sanofi. Dec 26, 2018 244
Japan : Daiichi Sankyo Out-Licenses ROS1/NTRK Inhibitor DS-6051 to AnHeart Therapeutics. Dec 20, 2018 315
Merus announces global settlement and ends litigation with Regeneron. Dec 20, 2018 134
Kineta Immuno-Oncology signs research collaboration with Pfizer. Dec 18, 2018 213
Kineta Immuno-Oncology signs research collaboration with Pfizer. Dec 18, 2018 209
Eli Lilly, Aduro Biotech announce research collaboration, license agreement. Dec 18, 2018 194
Eli Lilly, Aduro announce research collaboration for immunotherapy development. Dec 18, 2018 225
Kineta unit enters license agreement with Pfizer to develop cancer treatment. Dec 17, 2018 158
Eli Lilly, AC Immune to develop tau aggregation inhibitor small molecules. Dec 12, 2018 262
AC Immune, Eli Lilly announce license and collaboration agreement. Dec 12, 2018 265
Licensed brands give clout to variety of products. Dec 10, 2018 595
AbbVie signs HUMIRA global patent license with Pfizer. Dec 3, 2018 168
AbbVie signs HUMIRA global patent license with Pfizer. Dec 3, 2018 164
Advanced Accelerator, FUJIFILM Toyama Chemical sign option, license agreement. Dec 3, 2018 161
Argenx enters exclusive global collaboration, license agreement with Cilag. Dec 3, 2018 207
Argenx price target raised to $161 from $154 at Piper Jaffray. Dec 3, 2018 117
AbbVie signs patent license agreements with Pfizer over Humira biosimilar. Nov 30, 2018 139
$32 million court ruling in AbbVie drug case. Nov 29, 2018 363
Regulus amends and restructures agreement with Sanofi. Nov 6, 2018 122
Eli Lilly signs global licensing and research collaboration with Dicerna Pharmaceuticals. Oct 31, 2018 211
Eli Lilly signs global licensing and research collaboration with Dicerna Pharmaceuticals. Oct 31, 2018 207
Rigel Pharmaceuticals Inc signs exclusive license and supply agreement with Kissei Pharmaceutical Co Ltd. Oct 30, 2018 216
Rigel Pharmaceuticals Inc signs exclusive license and supply agreement with Kissei Pharmaceutical Co Ltd. Oct 30, 2018 212
Bristol-Myers Squibb doses first patient in clinical trial of BMS-986179. Oct 29, 2018 195
Bristol-Myers Squibb doses first patient in clinical trial of BMS-986179. Oct 29, 2018 191
Alvit LCS Pharma signs medical cannabis manufacturing and licensing agreement with Bazelet for Israel. Oct 25, 2018 197
Alvit LCS Pharma signs medical cannabis manufacturing and licensing agreement with Bazelet for Israel. Oct 25, 2018 193
Bristol-Myers doses first subject in Phase 1 trial using Halozyme's Enhanze. Oct 25, 2018 153
Japan : Application seeking manufacturing and marketing approval in Japan submitted for Parkinsons Disease Treatment Safinamide. Oct 25, 2018 200
China,United States : DiaMedica Therapeutics and Ahon Pharma, a Fosun Pharma Portfolio Company, Announces Signing of License Agreement for DM199 in China for Acute Ischemic Stroke. Oct 20, 2018 474
Boston Pharmaceuticals signs licensing and equity agreement with Novartis. Oct 5, 2018 208
Boston Pharmaceuticals signs licensing and equity agreement with Novartis. Oct 5, 2018 204
Arrowhead price target raised to $25 from $17 at Piper Jaffray. Oct 4, 2018 106
Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement. Oct 4, 2018 355
GO Therapeutics Enters into a License Agreement with Roche for New Glycotargeting Bispecific Cancer Treatment. Oct 3, 2018 208
Aduro dropped 13% after Janssen terminated license agreements. Oct 3, 2018 195
Janssen termination inconsequential for Aduro Biotech, says William Blair. Oct 3, 2018 128
Cellular signs licensing and collaboration agreement with Novartis in China. Sep 27, 2018 114
Eli Lilly, Chugai enter into license pact for OWL833. Sep 26, 2018 168
ITM and Merck KGaA Sign Research Evaluation and Option Agreement to Develop Folate Receptor Targeted Radionuclide Therapy. Sep 18, 2018 386
Novocure, Zai Lab announce strategic collaboration for Tumor Treating Fields. Sep 12, 2018 295
Novocure and Zai Lab Ink License Agreement for Tumor Treating Fields in Greater China. Sep 12, 2018 668
Active Biotech announces regain of global rights to development and commercialisation of laquinimod from Teva. Sep 6, 2018 252
Active Biotech announces regain of global rights to development and commercialisation of laquinimod from Teva. Sep 6, 2018 253
Biohaven Licenses Novel Myeloperoxidase Inhibitor from AstraZeneca: Potential First-In-Class Treatment for Multiple System Atrophy. Sep 6, 2018 479
JW Pharmaceutical Inks Global Out-Licensing Deal for Novel Atopic Dermatitis Drug Candidate. Aug 24, 2018 388
Cancer Prevention Pharmaceuticals signs licensing deal with Mallinckrodt for North America. Aug 14, 2018 234
Cancer Prevention Pharmaceuticals signs licensing deal with Mallinckrodt for North America. Aug 14, 2018 230
Shire and Shionogi submit New Drug Application for INTUNIV in Japan. Aug 13, 2018 182
Shire and Shionogi submit New Drug Application for INTUNIV in Japan. Aug 13, 2018 178
Perrigo Company plc announces licensing agreement in the US for Nasonex Nasal Spray under Rx-To-OTC Switch strategy. Aug 9, 2018 208
Immune Biosolutions Enters into a Research Collaboration and License Agreement with Johnson and Johnson Innovation to Identify and Develop Therapeutic Antibodies for Multiple Targets. Aug 9, 2018 173
Sanofi, Roche discontinue collaborations with Pieris Pharmaceuticals. Aug 9, 2018 270
Japan : Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate. Aug 8, 2018 371
IAVI, the Public Health Agency of Canada Enter into License Agreement for Technology to Enable Lassa Fever Vaccine Development. Aug 6, 2018 539
Gemphire in amended license pact with Pfizer. Aug 6, 2018 275
New Partnership Pairs Sutro Biopharma's Protein Synthesis Technology with Merck's Immunology and Cancer Expertise. Jul 26, 2018 241
Novartis commits to immuno-dermatology with new license agreement. Jul 19, 2018 199
Boehringer Ingelheim chooses to exercise exclusive license of human TCR-mimicking antibodies. Jul 19, 2018 213
Novartis commits to immuno-dermatology with new license agreement. Jul 19, 2018 195
Boehringer Ingelheim chooses to exercise exclusive license of human TCR-mimicking antibodies. Jul 19, 2018 209
Genmab and Immatics enter strategic partnership for bispecific cancer immunotherapies. Jul 12, 2018 241
Genmab and Immatics enter strategic partnership for bispecific cancer immunotherapies. Jul 12, 2018 237
Genmab announces strategic partnership with Immatics. Jul 12, 2018 288
Genmab announces strategic partnership with Immatics. Jul 12, 2018 289
Genmab announces strategic partnership with Immatics. Jul 12, 2018 284
Teneobio partners with Janssen to develop new multi-specific antibodies for cancer. Jul 9, 2018 172
Teneobio partners with Janssen to develop new multi-specific antibodies for cancer. Jul 9, 2018 168
Compugen reports FDA clearance of Bayer's IND application for BAY 1905254. Jul 2, 2018 203
OptiBiotix licenses LPLDL to Italian pharma company. Jun 21, 2018 150
OptiBiotix licenses LPLDL to Italian pharma company. Jun 21, 2018 146
REGENXBIO awarded USD100m in accelerated license payment. Jun 12, 2018 188
REGENXBIO awarded USD100m in accelerated license payment. Jun 12, 2018 184
Regenxbio receives $100M accelerated license payment. Jun 11, 2018 162
Janssen Begins Phase 1b/2 Clinical Development Program Evaluating CAR-T Cells for Treatment of Multiple Myeloma. Jun 4, 2018 211
BDD Pharma Licenses Timed-release OralogiK Technology to Novartis. Jun 4, 2018 195
Karo Pharmna receives USD6.0m milestone payment under agreement with Pfizer. May 22, 2018 193
Karo Pharmna receives USD6.0m milestone payment under agreement with Pfizer. May 22, 2018 189
Eiger BioPharmaceuticals expands license agreement with Merck. May 16, 2018 181
Aquinox and Astellas enter exclusive licensing agreement for rosiptor in Asia-Pacific region including Japan. May 10, 2018 241
Aquinox and Astellas enter exclusive licensing agreement for rosiptor in Asia-Pacific region including Japan. May 10, 2018 237
DURECT amends POSIMIR licensing agreement with Sandoz. May 10, 2018 231
DURECT amends POSIMIR licensing agreement with Sandoz. May 10, 2018 227
Caribou Biosciences Names Timothy F. Herpin, Ph.D. as Chief Business OIfficer. May 7, 2018 212
Arena Pharmaceuticals and Outpost Medicine Partner to Advance G Protein-coupled Receptor for Treatment of Genitourinary Disorders. May 4, 2018 236
Astellas Grants Exclusive License to Cardurion Pharmaceuticals to Develop Clinical Stage Heart Failure Candidate. Apr 18, 2018 235
Hanmi Pharm quits lung cancer drug development. Apr 13, 2018 332
Ligand Agreement Makes Worldwide OmniAb Platform License Accessible to venBio Portfolio Companies. Apr 5, 2018 259
Cellectis, Allogene intend to continue strategic collaboration. Apr 3, 2018 186
Compugen announces exclusive license agreement with MedImmune. Apr 2, 2018 156
Biohaven, BMS. Apr 1, 2018 277
India : Arysta Lifescience to deliver novel rice insecticide technology to India in partnership with Meiji Seika Pharma. Mar 31, 2018 313
Ligand enters OmniAb platform license agreement with venBio Partners. Mar 30, 2018 161
Xenon Pharmaceuticals confirms closing of transaction with Teva. Mar 28, 2018 354
Astex Collaborator Janssen Receives US FDA Breakthrough Therapy Designation for Erdafitinib for Metastatic Urothelial Cancer. Mar 20, 2018 235
Japan : Chugai Starts Activities towards Commercialization of Foundation Medicines Products in Japan. Mar 17, 2018 411
Biohaven, Bristol-Myers Squibb Restructure License Agreement to Reduce Migraine Product Candidate Royalties. Mar 14, 2018 297
Eisai Launches Gastrointestinal Prokinetic Agent Cidine (Cinitapride Hydrogen Tartrate) in China. Mar 14, 2018 745
Biohaven restructures license agreement with Bristol-Myers. Mar 12, 2018 286
Ligand Pharmaceuticals signs license agreement with Roivant Sciences. Mar 9, 2018 256
Ligand Pharmaceuticals signs license agreement with Roivant Sciences. Mar 9, 2018 252
United States : Mylan to Bring a Biosimilar of BOTOX to the Market Through a Collaboration and License agreement with Revance Therapeutics. Mar 3, 2018 365
Valeant Pharmaceutical's subsidiary signs contract with Kaken Pharmaceutical. Mar 1, 2018 193
Valeant Pharmaceutical's subsidiary signs contract with Kaken Pharmaceutical. Mar 1, 2018 189
Valeant to develop new chemical entity for psoriasis under licensing agreement with Kaken Pharmaceutical Co Ltd. Feb 28, 2018 216
Valeant to develop new chemical entity for psoriasis under licensing agreement with Kaken Pharmaceutical Co Ltd. Feb 28, 2018 212
Arbutus Biopharma settles litigation with Acuitas Therapeutics. Feb 22, 2018 130
United States : Elite Pharmaceuticals And SunGen Pharma File ANDA. Feb 9, 2018 234
BeiGene's VIDAZA commercially available in China. Feb 6, 2018 159
BeiGene's VIDAZA commercially available in China. Feb 6, 2018 155
Ligand, Ferring Pharmaceuticals Enter into Worldwide OmniAb Platform License Agreement. Jan 25, 2018 274
Lavasta Pharma to Distribute Innovus Pharma's ProstaGorx in Certain Middle Eastern and North African Countries. Jan 25, 2018 324
Eli Lilly's Elanco announces global pact with Ab E Discovery. Jan 25, 2018 180
Spark Therapeutics enters $105M licensing agreement with Novartis. Jan 24, 2018 156
Adlai Nortye signs EP4 antagonist global licensing agreement with Eisai. Jan 22, 2018 143
Adlai Nortye signs EP4 antagonist global licensing agreement with Eisai. Jan 22, 2018 139
Japan : Eisai Enters Into Licensing Agreement With Adlai Nortye for Potential Anticancer Agent E7046 (Prostaglandin E2 Receptor Type 4 Antagonist). Jan 20, 2018 288
Eisai Enters into Licensing Agreement with Adlai Nortye for Potential Anticancer Agent E7046. Jan 19, 2018 614
Glenmark Pharmaceuticals Licenses Ligand OmniAb Platform. Jan 16, 2018 230
Basilea completes licence agreement extension with Pfizer for Cresemba. Jan 10, 2018 218
Vanderbilt University and Lundbeck to collaborate on novel treatment approaches for schizophrenia. Jan 10, 2018 211
Basilea completes licence agreement extension with Pfizer for Cresemba. Jan 10, 2018 214
Vanderbilt University and Lundbeck to collaborate on novel treatment approaches for schizophrenia. Jan 10, 2018 207
Ligand Earns USD 6m from Antibody Project Out-Licensing. Jan 5, 2018 205
INTEGRATING NONFINANCIALS TO CREATE VALUE: Japanese companies have been leading the way in the adoption of integrated reporting and sustainability metrics. Yanagi, Ryohei; Michels-Kim, Nina Jan 1, 2018 3694
United States : Janssen Enters Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech to Develop Investigational CAR-T Anti-Cancer Therapy. Dec 23, 2017 409
vTv Therapeutics Licenses Rights to Diabetes Program to Chinese Pharmaceutical Company. Dec 22, 2017 383
GW Pharmaceuticals cancels license agreement with Otsuka Pharmaceutical. Dec 15, 2017 136
GW Pharmaceuticals cancels license agreement with Otsuka Pharmaceutical. Dec 15, 2017 132
United States : GW Pharma terminates Sativex license deal. Dec 15, 2017 209
Ono Pharmaceutical enters into licence agreement with Bristol-Myers Squibb. Dec 14, 2017 197
Ono Pharmaceutical enters into licence agreement with Bristol-Myers Squibb. Dec 14, 2017 193
Juno Therapeutics Signs Licensing Agreements with Lilly, OncoTracker, and Fred Hutchinson Cancer Research Center. Dec 12, 2017 277
Alexion to Utilise Halozyme Drug Delivery Technology to Develop SubQ Formulations. Dec 11, 2017 366
Basilea extends agreement with Pfizer for Cresemba to China and Asia Pacific. Dec 1, 2017 254
Basilea extends agreement with Pfizer for Cresemba to China and Asia Pacific. Dec 1, 2017 250
Palatin Technologies signs collaboration and license agreement with Kwangdong Pharmaceutical Co Ltd for bremelanotide for treating FSD in Korea. Nov 22, 2017 290
Palatin Technologies signs collaboration and license agreement with Kwangdong Pharmaceutical Co Ltd for bremelanotide for treating FSD in Korea. Nov 22, 2017 286
Cue Biopharma, Merck sign strategic research collaboration and license agreement. Nov 20, 2017 158
Cue Biopharma, Merck sign strategic research collaboration and license agreement. Nov 20, 2017 154
Spark Therapeutics amends license agreement with Pfizer for SPK-9001. Nov 9, 2017 271
Spark Therapeutics amends license agreement with Pfizer for SPK-9001. Nov 9, 2017 267
UroGen Pharma and Allergan enrol first patient in Phase 2 clinical trial of RTGel/BOTOX. Nov 6, 2017 216
UroGen Pharma and Allergan enrol first patient in Phase 2 clinical trial of RTGel/BOTOX. Nov 6, 2017 212
Boehringer Ingelheim and Dicerna collaborating on development of RNAi therapeutics for liver disease. Nov 3, 2017 232
Boehringer Ingelheim and Dicerna collaborating on development of RNAi therapeutics for liver disease. Nov 3, 2017 228
Basilea provides update on commercial progress of Cresemba in Europe. Nov 2, 2017 213
Lannett and Celgene Enter Into Settlement, License Agreement Related to Thalomid. Nov 2, 2017 231
Lannett signs settlement and license agreement with Celgene. Nov 1, 2017 167
Lannett signs settlement and license agreement with Celgene. Nov 1, 2017 163
Japan : Daiichi Sankyo and Glycotope Announce Option Agreement for Antibody Drug Conjugate Strategic Collaboration and Licensing. Oct 30, 2017 367
United States : Sunovion Announces Seebri Neohaler (glycopyrrolate) Inhalation Powder is Now Available in the United States. Oct 23, 2017 221
Astellas Institute for Regenerative Medicine, Universal Cells sign license agreement. Oct 20, 2017 287
Astellas Institute for Regenerative Medicine, Universal Cells sign license agreement. Oct 20, 2017 283
Bristol-Myers Squibb to License Enhanze Drug-Delivery Technology Technology from Halozyme. Sep 15, 2017 385
Boehringer Ingelheim signs collaboration and license agreement with Gubra. Sep 12, 2017 183
Malaysia,United States : US pharma company to expand Hepatitis C generic licensing deal to Malaysia. Sep 7, 2017 257
Ionis awarded USD40m in milestone payment from Biogen. Aug 31, 2017 266
Ionis awarded USD40m in milestone payment from Biogen. Aug 31, 2017 262
Daiichi Sankyo grants license for highly selective RET inhibitor to Boston. Aug 29, 2017 210
Daiichi Sankyo grants license for highly selective RET inhibitor to Boston. Aug 29, 2017 206
Germany : Bayer donates proprietary data and joins forces with Quantified Planet, enabling research into biodiversity. Aug 28, 2017 447
Otsuka signs license agreement for delamanid for treating pulmonary multidrug-resistant tuberculosis in low- and middle-income countries. Aug 24, 2017 337
Otsuka and Mylan agree licence deal for tuberculosis treatment. Aug 24, 2017 280
Otsuka signs license agreement for delamanid for treating pulmonary multidrug-resistant tuberculosis in low- and middle-income countries. Aug 24, 2017 333
Otsuka and Mylan agree licence deal for tuberculosis treatment. Aug 24, 2017 276
Hikma Pharmaceuticals expands licensing agreement with Takeda for products in MENA. Aug 17, 2017 211
Hikma expands licensing agreement for Alogliptin, Azilsartan, Dexlansoprozole and Lornoxicam for MENA. Aug 17, 2017 239
Hikma Pharmaceuticals expands licensing agreement with Takeda for products in MENA. Aug 17, 2017 207
Hikma expands licensing agreement for Alogliptin, Azilsartan, Dexlansoprozole and Lornoxicam for MENA. Aug 17, 2017 235
Shuttle Pharmaceuticals signs doranidazole license agreement with POLA. Aug 16, 2017 222
Shuttle Pharmaceuticals signs doranidazole license agreement with POLA. Aug 16, 2017 218
Tabuk Pharmaceuticals enters into exclusive in-licensing agreement with Dong A for Zydena in Saudi Arabia and the Gulf area. Jul 31, 2017 154
Bristol-Myers Squibb partners with Medicines Patent Pool to extend atazanavir licence for PLHIV in 122 developing countries. Jul 26, 2017 224
AMO Pharma announces development and license agreement for AMO-04 with Numedicus Limited for Rett Syndrome Programme. Jul 21, 2017 194
AMO Pharma announces development and license agreement for AMO-04 with Numedicus Limited for Rett Syndrome Programme. Jul 21, 2017 190
Pfizer Obtains Exclusive European Commercialisation Rights for Cresemba. Jul 21, 2017 292
United States : Pfizer Completes License Agreement For The Exclusive Commercialization Rights In Europe For CRESEMBA (isavuconazole). Jul 21, 2017 248
Ablynx and Sanofi enter strategic collaboration to develop Nanobody product candidates. Jul 20, 2017 236
Licence agreement between Basilea and Pfizer for antifungal Cresemba is complete. Jul 20, 2017 209
AMO Pharma agrees development and licence deal with Numedicus. Jul 20, 2017 191
Ablynx and Sanofi enter strategic collaboration to develop Nanobody product candidates. Jul 20, 2017 232
Licence agreement between Basilea and Pfizer for antifungal Cresemba is complete. Jul 20, 2017 205
AMO Pharma agrees development and licence deal with Numedicus. Jul 20, 2017 187
Shire enters licence agreement for Novimmune bi-specific antibody. Jul 19, 2017 233
Shire enters licence agreement for Novimmune bi-specific antibody. Jul 19, 2017 229
Oncology Venture signs agreement with Novartis Pharma to evaluate in-licensing potential of small molecule compound. Jul 19, 2017 221
United States : Cytovia Inc, Immune Pharmaceuticals Oncology Subsidiary, Enters into a Definitive Agreement with Pint Pharma for the Licensing and Commercialization of Ceplene in Latin America. Jul 13, 2017 309
United States : Elite Announces New Development and License Agreement with SunGen Pharma LLC. Jul 13, 2017 277
Arrien Completes Worldwide License Agreement for ARN-6039 for Treatment of Psoriasis and Other Autoimmune Disorders. Jun 29, 2017 348
Takeda and Biologics E. enter into vaccines agreement. Jun 26, 2017 190
Takeda and Biologics E. enter into vaccines agreement. Jun 26, 2017 186
Basilea Pharmaceutica International signs license agreement with Pfizer. Jun 19, 2017 147

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters